DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Alpha-1 Anti-Trypsin Deficiency Forecast in 9 Major Markets 2016-2026" report to their offering.
Alpha-1 Anti-Trypsin deficiency (AATD) is an inherited, rare condition that causes a complete or partial reduction in activity of Alpha-1 Anti-Trypsin (AAT) in the blood and lungs which leads to the deposit of excessive abnormal A1AT protein in liver cells.
This report provides the current prevalent population for Alpha-1 Anti-Trypsin across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Reasons to Buy:
- Able to quantify patient populations in the global Alpha-1 Anti-Trypsin market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of Alpha-1 Anti-Trypsin and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on the Alpha-1 Anti-Trypsin prevalent population.
- Identify sub-populations within Alpha-1 Anti-Trypsin which require treatment.
- Gain an understanding of the specific markets that have the largest number of Alpha-1 Anti-Trypsin patients.
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key comorbid conditions
8. Methodology for quantification of patient numbers
9. Top-line prevalence
10. Features of AATD patients
11. Abbreviations used in the report
12. Patient-Based Offering
13. Online Pricing Data and Platforms
14. References
15. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/c2d28r/alpha1
